- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02582281
Non Touch Technique for IUD Insertion
The Non Touch Technique for Intrauterine Device Insertion, a Single Blinded Randomized Control Trial
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Cairo, Egypt, 12211
- Recruiting
- Kasr El Aini Hospital
-
Principal Investigator:
- Dina M Dakhly, MD
-
Contact:
- Dina M Dakhly, MD
- Phone Number: 002 01003498919
- Email: dinadakhly@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Females desiring contraception with the use of IUD
Exclusion Criteria:
- Are pregnant or think they may be pregnant
- Septic pregnancy or abortion
- Have unexplained abnormal vaginal bleeding
- Have untreated cervical cancer
- Have malignant gestational trophoblastic disease
- Have uterine cancer
- Have uterine abnormalities
- Have or may have had a pelvic infection within the past three months
- Have or may have any sexually transmitted disease
- Have pelvic tuberculosis
- Are postpartum between 48 hours and 4 weeks
- Have benign gestational trophoblastic disease
- Have ovarian cancer
- Have AIDS (unless clinically well on anti-retroviral therapy)
Study Plan
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Non touch technique
the intrauterine device TCu 380A will be inserted in the conventional method as follows: First, insert the speculum and view the cervix. The position of the cervix will very often confirm if the uterus is anteverted or retroverted. Second, using the Allis forceps hold the back of a cotton-ball swab and dip it into a povidine-iodine disinfectant solution, or equivalent. Swab the cervix. Then cut the threads to the appropriate length and remove the speculum. This technique omits the sounding of the uterus which is considered a quintessential procedure before IUD insertion for which there is no one established piece of evidence.The IUD is checked afterwards by transvaginal ultrasound. |
Other Names:
|
|
Experimental: Traditional IUD insertion
the intrauterine device TCu 380A will be inserted in the conventional method, and checked afterwards by transvaginal ultrasound.
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
degree of pain during IUD insertion
Time Frame: 5 months
|
Pain will be assessed by the use of visual analog scale (VAS).
|
5 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Dina M Dakhly, MD, Cairo university
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- CU161020
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Contraception
-
Virginia Commonwealth UniversityCompletedPregnancy Related | Contraception | Contraception Behavior | Contraception Use
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedFemale Contraception | Contraception
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Medical University of South CarolinaSociety of Family PlanningCompletedContraception | Contraception BehaviorUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedFemale Contraception | ContraceptionUnited States, Israel
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedFemale Contraception | Contraception
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedFemale Contraception | Contraception
-
Janssen Pharmaceutica N.V., BelgiumCompleted
-
University of California, Los AngelesCompletedContraception | Mobile Applications | Contraception BehaviorUnited States
Clinical Trials on intrauterine device TCu 380A
-
Woman's Health University Hospital, EgyptCompleted
-
Woman's Health University Hospital, EgyptUnknown
-
Hospital de Clinicas de Porto AlegreCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Federal University...Completed
-
Seattle Children's HospitalEunice Kennedy Shriver National Institute of Child Health and Human Development...Not yet recruitingVaginal Microbial DiversityKenya
-
Cairo UniversityCompletedContraceptive Device; ComplicationsEgypt
-
University of Alabama at BirminghamCompletedHIV Infections | HIV | ContraceptionZambia
-
University of British ColumbiaTerminatedInduced Abortion
-
Assiut UniversityNot yet recruitingQuality of Life
-
University of British ColumbiaTerminated
-
Rutgers, The State University of New JerseyCompleted